Table 1.
Study period | |||||
---|---|---|---|---|---|
Enrollment | Allocation | Post allocation | Close-out | ||
Timepoint | −t1 | 0 | t1 | t15 | t16 |
Enrollment: | |||||
Eligibility screen | X | ||||
Informed consent | X | ||||
BIT-C and HADa | X | ||||
MMSEb | X | ||||
EHIc | X | ||||
Allocation | X | ||||
Interventions: | |||||
Anodal tDCSd | X | X | |||
Cathodal tDCSe | X | X | |||
Anodal placebo | X | X | |||
Cathodal placebo | X | X | |||
Assessments: | |||||
BIT-Ca | X | ||||
CBSf | X | X | |||
NIHSS, FIM and BIg | X | X | |||
mRSh | X | X | |||
Quality of lifei | X | X |
aConventional Behavior Inattention Tasks and Hospital Anxiety and Depression Scale
bMini-mental State Examination
cEdinburgh Handedness Inventory
dAnodal tDCS applied over left parietal lobe (P3)
eCathodal tDCS applied over right parietal lobe (P4)
fCatherine Bergego Scale
gNational Institutes of Health Stroke Scale, Functional Independence Measure and Barthel Index
hModified Rankin Scale
iQuality of life measured by The European Quality of Life Scale (EuroQol 5D)